Polypipe Group /£GEN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Polypipe Group

Polypipe Group, trading under the ticker GEN, is a manufacturer specializing in water management and plastic piping systems. Established in 1980, the company operates primarily within the construction and infrastructure sectors. Polypipe offers a wide range of products aimed at addressing critical challenges in water, climate, and ventilation management, contributing to the development of green building solutions.

Ticker

£GEN

Primary listing

LSE

Employees

3,200

Polypipe Group Metrics

BasicAdvanced
£855M
17.69
£0.19
1.40
£0.13
3.64%

What the Analysts think about Polypipe Group

Analyst ratings (Buy, Hold, Sell) for Polypipe Group stock.

Bulls say / Bears say

RBC Capital Markets upgraded Genuit to “Outperform” from “Sector Perform”, citing the stock’s undervaluation at 11x 2025 EV/adjusted EBIT compared to peers and potential growth from regulatory catalysts such as AMP8 and the Future Homes Standard
Group revenue for H1 2025 rose 9.3% to £297.8 million (6.1% like-for-like), showing a return to top-line growth in a flat market through focused price and volume strategies
Leverage improved to 1.0x pro-forma EBITDA as of June 30, 2025 (from 1.1x), strengthening the balance sheet and giving the company more flexibility for disciplined bolt-on acquisitions
Underlying operating margin dropped by 100 basis points to 15.0% in H1 2025 due to increased National Insurance and minimum wage expenses impacting profitability
Underlying operating cash conversion fell to 65.1% from 99.5% a year earlier, indicating working capital pressures from higher inventory provisions and timing effects
Genuit’s shares declined over 7% following the H1 2025 results, as investors worried about persistent cost pressures and stagnant market volumes even with top-line growth
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2025.

Polypipe Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Polypipe Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £GEN

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Oct1
Polypipe Group
DividendPayment
£0.042Per share
FAQs